Article
Rapid and efficient detection of EGFR mutations in problematic cytologic specimens by high-resolution melting analysis.
Molecular diagnosis & therapy - 1 Feb 2011
Hlinkova Katarina, Babál Pavel, Berzinec Peter, Majer Ivan, Ilencikova Denisa
Abstract excerpt
BACKGROUND AND OBJECTIVE: Chemotherapy for advanced non-small-cell lung cancer (NSCLC) remains marginally effective, with a 5-year overall survival rate of approximately 5%. Recently, the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib was approved in Slovakia for the treatment of metastatic NSCLC. Gefitinib is a selective EGFR inhibitor that binds to the adenosine triphosphate binding...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
